MedPath

Curemark

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:1
Completed:3

Trial Phases

1 Phases

Phase 3:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)โ€ข Click on a phase to view related trials

Phase 3
4 (100.0%)

An Open Label Study of CM-AT for the Treatment of Children With Autism

Phase 3
Active, not recruiting
Conditions
Autism
Interventions
First Posted Date
2016-01-08
Last Posted Date
2025-02-13
Lead Sponsor
Curemark
Target Recruit Count
405
Registration Number
NCT02649959
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Southwest Autism Research & Resource Center (S.A.R.R.C.), Phoenix, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Arizona, Pediatrics Multidisciplinary Research Unit, Tucson, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Arkansas Children'S Hosp. Research Institute (A.C.H.R.I.), Little Rock, Arkansas, United States

and more 28 locations

A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study)

Phase 3
Completed
Conditions
Autism
Interventions
Drug: PLACEBO
First Posted Date
2015-04-08
Last Posted Date
2023-05-24
Lead Sponsor
Curemark
Target Recruit Count
190
Registration Number
NCT02410902
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Southwest Autism Research & Resource Center (S.A.R.R.C.), Phoenix, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Arizona, Pediatrics Multidisciplinary Research Unit, Tucson, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Arkansas Children'S Hosp. Research Institute (A.C.H.R.I.), Little Rock, Arkansas, United States

and more 27 locations

A Trial of CM-AT in Children With Autism- Open Label Extension Study

Phase 3
Completed
Conditions
Autism
Interventions
First Posted Date
2009-06-03
Last Posted Date
2019-03-01
Lead Sponsor
Curemark
Target Recruit Count
165
Registration Number
NCT00912691
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Southwest Autism Research and Resource Center, Phoenix, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of California, Davis, M.I.N.D. Institute, Sacramento, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of California, San Francisco, San Francisco, California, United States

and more 16 locations

A Trial of CM-AT in Children With Autism

Phase 3
Completed
Conditions
Autism
Interventions
Drug: Placebo
First Posted Date
2009-04-15
Last Posted Date
2018-04-19
Lead Sponsor
Curemark
Target Recruit Count
182
Registration Number
NCT00881452
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Southwest Autism Research and Resource Center, Phoenix, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of California, Davis, M.I.N.D. Institute, Sacramento, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of California, San Francisco, San Francisco, California, United States

and more 16 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.